Over 40% of high school students vape. Most e-cigarette liquid contains purified nicotine, making them equally addictive as conventional cigarettes. Prof. Shama Ahmad (University of Alabama at Birmingham, USA) pointed out that nicotine vapours in new devices, such as the electronic IQOS, are generated using low heat, and are therefore marketed as “safer e-cigs”. However, the nicotine content of these products is on the rise, often even exceeding those of a traditional cigarette. They exert rapid physiological effects, including a significant increase in peripheral airway resistance and an elevated heart rate. According to Prof. Ahmad’s hypothesis, acute high concentration nicotine inhalation causes increased inflammation and lung injury through the release of damage-associated molecular patterns (DAMPS). This has been shown in experimental animals. Inhaled nicotine causes an increase of different inflammatory cells, such as neutrophils, eosinophils, and basophils. In addition, a loss of pulmonary barrier proteins measured by transepithelial electrical resistance, a decrease in E-cadherin expression, and an increase in epithelial cell death has been demonstrated. The additional release of proinflammatory cytokines like TNF, IL-6 and IL-8 following cigarette smoking perpetuates chronic inflammatory processes in e-smokers. Epithelial cell death and inflammation have also been demonstrated following nicotine inhalation in human alveolar epithelial cells. Thus, Prof. Ahmad concluded, the claim of a “healthier” cigarette is not justified.
- Ahmad S. Electronic cigarette nicotine-mediated lung damage: Is it nicotine or DAMPs or both? Session A90, ATS 2020 Virtual, 5-10 Aug.
Posted on
Previous Article
« Social smoking: Do not underestimate the risks Next Article
Poly-use of nicotine products and cannabis: a deadly combination »
« Social smoking: Do not underestimate the risks Next Article
Poly-use of nicotine products and cannabis: a deadly combination »
Table of Contents: ERS 2020
Featured articles
COVID-19 and the Lung
COVID-19 infections: Bronchoscopy provides additional diagnostic certainty
COVID-19 vaccines: An ongoing race
COVID-19: What is the risk of reinfection?
COVID-19 App: The Dutch experience
Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19
COVID-19 survivors benefit from structured follow-up
Early pulmonary rehabilitation post-COVID-19 aids recovery
Asthma – What's New
Mild asthma: A fundamental change in management
Dupilumab shows long-term efficacy in asthma patients
Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity
First-in-class tyrosine kinase inhibitor shows promise in severe asthma
Predicting individual effectiveness of biologics in severe asthma
IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps
Treatment according to genotype: The future of asthma therapy?
COPD – The Beat Goes On
The role of chronic symptoms as early biomarkers of COPD development
Urgent call for studies in COPD patients aged 40-60 years
Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients
Exacerbation history is a reliable predictor of future exacerbations
Singing training effective as physical rehabilitation in COPD
Current prediction tools underestimate exacerbation risk of severe COPD patients
Exercise and Sleep: From Impaired Function to New Therapeutic Strategies
CPAP withdrawal has negative consequences for sleep apnoea patients
Physical activity improves AHI in sleep apnoea patients
The Tobacco Epidemic: From Vaping to Cannabis
Poly-use of nicotine products and cannabis: a deadly combination
E-cigarettes: A source of chronic lung inflammation
Social smoking: Do not underestimate the risks
Chronic Cough – State of the Art
LEAD study shows multiple phenotypes in many chronic cough patients
First-in-class P2X3 receptor antagonist shows promise for chronic cough treatment
Lung Cancer Detection
Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis
Distinct changes in lung microbiome precede clinical diagnosis of lung cancer
Best of Posters
Smartphone-based cough detection helpful in predicting asthma deterioration
Reduced lung function associated with cognitive decline in the elderly
Longer hospital stay and fewer transplants for frail ILD patients
Related Articles
February 26, 2024
Join the conversation on Rare Disease Awareness Day
September 22, 2022
ERS 2022 Highlights Podcast
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com